Agency for Healthcare Research and Quality, Grant/Award Number: HHSA 290-2015-00002-I
AHRQ, Agency for Healthcare Research and Quality; CGRP, calcitonin gene-related peptide; EPC, Evidence-based Practice Center; NHLBI, National Heart, Lung, and Blood Institute; NMDA, N-methyl-D-aspartate; NRCS, nonrandomized comparative study; NSAID, nonsteroidal anti-inflammatory drug; RCT, randomized controlled trial; RoB, risk of bias; ROBINS-I, Risk of Bias in Nonrandomized Studies of Interventions; SNRI, serotonin and norepinephrine reuptake inhibitor; SoE, strength of evidence; SR, systematic review; TAC, trigeminal autonomic cephalalgia.
We would like to thank Michael Carson, MD, Matthew Collins, MD, MBA, Elisabeth Howard PhD, Elizabeth Loder, MD, MPH, Wanda Nicolson, MD, MPH, MBA, Brandi Ring, MD, Leyla Sahin, MD, Jonathan Schaffir, MD, Amaal Starling, MD, and Catherina Stika, MD, who served as key informants and/or technical experts and helped us refine the research questions and develop the protocol. We are also grateful to the project's Task Order Officers Jill Huppert, MD, MPH and Suchitra Iyer, PhD at the Agency for Healthcare Research and Quality, Rockville, Maryland and to the full systematic review report's Associate Editor Marian McDonagh, PhD at the Pacific Northwest Evidence-based Practice Center, Portland, Oregon. We also thank Hannah J. Kimmel, MPH, Melissa R. Riester, PharmD, and Mark N. Sorial, PharmD for their careful study screening and related contributions to the project.
Headache. 2021;61(1):11-43. © 2021 Blackwell Publishing